Appili Therapeutics (APLIF) Stock Chart & Stock Price History $0.01 0.00 (0.00%) As of 07/9/2025 01:24 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock Appili Therapeutics Stock Price Performance The Appili Therapeutics (APLIF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 57.49%, with a year-to-date return of -57.86%. In the past month, the stock has decreased 9.23%, reflecting recent market activity. As of the latest close, Appili Therapeutics traded at $0.01 with a market cap of $1.43 million and volume of 50,000 shares. Receive APLIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.28%1 Month Performance-9.23%3 Month Performance-45.37%Year-To-Date Performance-57.86%1 Year Performance-57.49% APLIF Stock Chart for Thursday, July, 10, 2025 APLIF Chart by TradingView Appili Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/09/2025$0.01$0.01$0.01$0.0150,000 shs$1.43 million07/08/2025$0.01$0.01$0.01$0.0114,000 shs$1.43 million07/07/2025$0.01$0.01-3.28%$0.01$0.0114,000 shs$1.43 million07/04/2025$0.01$0.01$0.01$0.011,905 shs$1.48 million07/03/2025$0.01$0.01+37.08%$0.01$0.011,905 shs$1.48 million07/02/2025$0.01$0.01$0.01$0.0110,000 shs$1.08 million07/01/2025$0.01$0.01-35.51%$0.01$0.0110,000 shs$1.08 million06/30/2025$0.01$0.01+33.98%$0.01$0.0140,000 shs$1.67 million06/27/2025$0.01$0.01-1.90%$0.01$0.01300 shs$1.25 million06/26/2025$0.01$0.01$0.01$0.01222,900 shs$1.27 million Get the Latest News and Ratings for APLIF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/25/2025$0.01$0.01-2.78%$0.01$0.01222,900 shs$1.27 million06/24/2025$0.01$0.01-7.69%$0.01$0.01100 shs$1.31 million06/23/2025$0.01$0.01+10.80%$0.01$0.0174,100 shs$1.42 million06/18/2025$0.01$0.01$0.01$0.0168,975 shs$1.29 million06/17/2025$0.01$0.01-13.47%$0.01$0.0168,975 shs$1.29 million06/13/2025$0.01$0.01$0.01$0.01200 shs$1.49 million06/12/2025$0.01$0.01-12.14%$0.01$0.01200 shs$1.49 million06/11/2025$0.01$0.01+7.69%$0.01$0.01100 shs$1.70 million06/10/2025$0.01$0.01-6.47%$0.02$0.015,100 shs$1.58 million06/09/2025$0.01$0.01+29.91%$0.01$0.0134,000 shs$1.69 million Related Companies CYCC Stock Price Chart KTTA Stock Price Chart ENSC Stock Price Chart ATNF Stock Price Chart MBIO Stock Price Chart ALBT Stock Price Chart UBX Stock Price Chart CNSP Stock Price Chart MYNZ Stock Price Chart MBRX Stock Price Chart Receive APLIF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:APLIF) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appili Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Appili Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLIF Stock Alerts